Next-Generation Sequencing (NGS) Market: A Deep Dive into Size, Segmentation, and Competitive Landscape
Next-Generation Sequencing (NGS) Market Size
The Global Next-Generation Sequencing (NGS) Market was valued at USD 7,744.30 Million in 2021 and is projected to grow from USD XX Million in 2022 to USD 45,017.81 Million by 2030, expanding at a robust CAGR of 21.6% during the forecast period (2022–2030). This exponential growth is driven by advancements in sequencing technologies, increasing applications in personalized medicine, and rising demand for genetic screening and diagnostics.
Request a free request sample https://straitsresearch.com/report/next-generation-sequencing-market/request-sample
Catalysts for Expansion
The NGS market is experiencing rapid growth due to several key factors:
Technological Advancements: Continuous innovations in sequencing technologies, such as single-molecule real-time sequencing and nanopore sequencing, are enhancing the accuracy, speed, and cost-effectiveness of NGS platforms.
Rising Demand for Personalized Medicine: NGS is playing a pivotal role in the development of personalized medicine, enabling tailored treatments based on individual genetic profiles.
Increasing Applications in Oncology: NGS is revolutionizing cancer diagnostics and treatment by enabling early detection, companion diagnostics, and targeted therapies.
Growing Adoption in Agriculture and Animal Research: NGS is being widely used in agrigenomics for crop improvement, disease resistance, and livestock breeding.
Government and Private Sector Investments: Increased funding for genomics research and the establishment of large-scale sequencing projects are propelling market growth.
Market Segment Breakdown
The NGS market is segmented based on type of sequencing, product type, end-user, applications, and technology.
1. By Type of Sequencing
Whole Genome Sequencing
Targeted Sequencing Resequencing
DNA-based
RNA-based
Whole Exome Sequencing
RNA Sequencing
CHIP Sequencing
De Novo Sequencing
Methyl Sequencing
2. By Product Type
Instruments
Reagents and Consumables
Services
3. By End-User
Hospitals and Clinical Laboratories
Academics and Research Institutions
Pharmaceutical and Biotechnology Companies
4. By Applications
Drug Discovery and Personalized Medicine
Genetic Screening
Agriculture and Animal Research
Biomarkers and Cancer
Oncology
Diagnostics and Screening
Oncology Screening
Sporadic Cancer
Inherited Cancer
Companion Diagnostics
Other Diagnostics
Research Studies
Clinical Investigation
Infectious Diseases
Inherited Diseases
Idiopathic Diseases
Non-Communicable/Other Diseases
Reproductive Health
NIPT
Aneuploidy
Microdeletions
PGT
Newborn Genetic Screening
Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology Drug Development
Agrigenomics Forensics
Consumer Genomics
5. By Technology
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real-Time Sequencing
Other Technologies
This Report is available for purchase on https://straitsresearch.com/buy-now/next-generation-sequencing-market
Top Performing Companies
The NGS market is highly competitive, with key players driving innovation and market expansion. The top-performing companies include:
Agilent Technologies
Bio-Rad Laboratories Inc.
DNASTAR Inc.
Eurofins Scientific
Hoffmann-La Roche Ltd
Illumina Inc.
Danaher Corporation (IDT)
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Qiagen
Thermo Fisher Scientific Inc.
These companies are focusing on strategic collaborations, product launches, and technological advancements to strengthen their market position.
Emerging Prospects
The NGS market is poised for significant growth, with several emerging opportunities:
Integration of AI and Machine Learning: The incorporation of AI and machine learning in NGS data analysis is enhancing the accuracy and efficiency of genomic interpretations.
Expansion in Emerging Markets: Increasing adoption of NGS technologies in emerging economies, such as India, China, and Brazil, is creating new growth avenues.
Rise of Direct-to-Consumer Genetic Testing: The growing popularity of consumer genomics is driving demand for NGS-based genetic testing kits.
Advancements in Single-Cell Sequencing: Single-cell sequencing technologies are opening new possibilities in understanding cellular heterogeneity and disease mechanisms.
Industry Movements
The NGS market is witnessing several notable trends and developments:
Mergers and Acquisitions: Companies are engaging in mergers and acquisitions to expand their product portfolios and geographic reach.
Collaborations and Partnerships: Strategic collaborations between NGS companies, research institutions, and healthcare providers are fostering innovation and accelerating market growth.
Focus on Cost Reduction: Efforts to reduce the cost of sequencing are making NGS more accessible to a broader range of users.
Regulatory Approvals: Increasing regulatory approvals for NGS-based diagnostic tests are boosting market confidence and adoption.
Geographic Analysis
The NGS market is analyzed across key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East Africa. North America currently dominates the market, driven by advanced healthcare infrastructure, significant RD investments, and the presence of major market players. However, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period, owing to increasing healthcare expenditure, rising awareness about genetic disorders, and government initiatives to promote genomics research.
Data Insights
The report provides valuable data insights, including market size and forecasts, competitive landscape analysis, and detailed segment-wise breakdowns. It also offers strategic recommendations for stakeholders to capitalize on emerging opportunities and navigate market challenges.
Conclusion
The Next-Generation Sequencing (NGS) Market is on a trajectory of unprecedented growth, driven by technological advancements, expanding applications, and increasing investments. Straits Research’s comprehensive report offers a holistic view of the market, equipping stakeholders with the insights needed to make informed decisions and stay ahead in this dynamic landscape.
About Straits Research
Straits Research is a leading market research and consulting firm specializing in providing actionable insights and strategic recommendations to businesses across various industries. With a team of experienced analysts and a robust methodology, Straits Research delivers high-quality market intelligence to help clients achieve their business objectives.
FAQs About the Next-Generation Sequencing (NGS) Market
What is the current size of the Next-Generation Sequencing (NGS) Market?
The global NGS market was valued at USD 7,744.30 Million in 2021 and is projected to grow significantly in the coming years.What is the projected growth of the NGS Market by 2030?
The NGS market is expected to reach USD 45,017.81 Million by 2030, growing at a CAGR of 21.6% during the forecast period (2022–2030).What are the key drivers of the NGS Market’s growth?
The growth is driven by advancements in sequencing technologies, rising demand for personalized medicine, and increasing applications in oncology and agriculture.Which companies are leading the NGS Market?
Top players include Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies, and Hoffmann-La Roche Ltd, among others.What are the major applications of Next-Generation Sequencing?
NGS is widely used in drug discovery, cancer diagnostics, genetic screening, reproductive health, and agrigenomics, among other applications.
